Medimaging Integrated Solution Inc. (TPE: 6796)

Market Cap	3.04B
Revenue (ttm)	473.88M
Net Income (ttm)	-14.69M
Shares Out	34.75M
EPS (ttm)	-0.43
PE Ratio	n/a
Forward PE	n/a
Dividend	1.80 (2.07%)
Ex-Dividend Date	Jul 19, 2024

Volume	28,544
Open	87.00
Previous Close	87.00
Day's Range	86.50 - 87.70
52-Week Range	72.70 - 110.50
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 26, 2025

About Medimaging Integrated Solution

Medimaging Integrated Solution Inc. provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope, including optical coherence tomography, control unit scopes, software, and accessories; computing-based AI screening in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions, a micro camera module for visualization performance and provides patient-oriented care; and micro camera modules. Medimaging Integrate...

• Industry: Healthcare
• Sector: Healthcare
• Founded: 2010
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6796

Financial Performance

In 2023, Medimaging Integrated Solution's revenue was 537.15 million, an increase of 6.98% compared to the previous year's 502.09 million. Earnings were 74.05 million, an increase of 5.76%.